معرفی
Mef Nilbert serves as an Adjunct Professor and Principal Investigator at Lund University's Faculty of Medicine, with primary affiliations at the Lund University Cancer Center (LUCC), EpiHealth: Epidemiology for Health, and the Breast Cancer Genetics research group. As a prominent researcher in cancer genetics, Dr. Nilbert leads multiple projects focused on hereditary cancer syndromes and sarcoma research.
Dr. Nilbert's research program centers on two main areas: hereditary colorectal cancer (particularly Lynch syndrome and Familial Colorectal Cancer Type X) and sarcoma biology. The colorectal cancer research focuses on refined risk assessment modeling, identification of genetic causes, analysis of interval cancers, and development of new sequencing strategies to identify disease-associated genes. The sarcoma research aims to define genetic profiles of radiation-induced sarcomas, identify metastasis risk markers, and evaluate prognostic biomarkers in specific sarcoma types. This work contributes significantly to the UN Sustainable Development Goals related to health and well-being.
The research output shows a strong emphasis on translational cancer genetics, with publications spanning molecular mechanisms of tumor development, clinical risk assessment, and population-based cancer screening. Recent work has particularly focused on mismatch repair deficiency in colorectal cancer and its implications for screening programs and genetic counseling.
Dr. Nilbert actively participates in cancer research leadership, serving on program committees for major conferences including the Lund University Cancer Centre meetings, National Comprehensive Cancer Centre meetings, and the Medicon Valley Alliance Oncology Network. Current projects include 'Precision Medicine in Hereditary Cancer and Sarcoma' and 'Orthopaedic oncology; clinical management and outcomes of soft tissue sarcoma.'
As a supervisor, Dr. Nilbert mentors multiple doctoral students and researchers, with 19 supervised works documented. The research network includes collaborations across multiple institutions focused on cancer genetics and epidemiology, with particular emphasis on international comparative studies in cancer screening and genetic risk assessment.
